Korean J Med.  1997 May;52(5):678-684.

A Case of Adrenal Cortical Carcinoma with Invasion of Inferior Vena Cava

• Yoon MH
• Goo SH
• Chung YS
• Kim HM
• Kim HS
• Kim HC
• Park HB
• Yim HE

Abstract

The adrenal cortical carcinoma is a rare cancer with an estimated incidence of about 1 case per 1,700,000 population. Further development of the tumor thrombi invasion of the inferior vena cava is very rare. The adrenal cortical carcinoma has poor prognosis due to delayed onset of symptoms and signs with regional and metastatic diseases are about 70M at the time of diagnosis. The diagnosis is made by hormonal and imaging studies. Adrenal cortical carcinoma is slightly more frequent in female and hormonally non-functioning tumor is more frequent. Traditionally, surgery and mitotane chemotherapy are known as a valuable therapeutic modality. But recently usefullness of mitotane is questioned due to low response rate and complication such as gastrointestinal trouble and there is not established optimal dosage and duration of treatment. Recently, in metastatic adrenal cortical carcinoma, some literature with combined chemotherapy had tried and reported good response. But, in general, combined chemotherapy has known as ineffective. We experienced and report adrenal cortical carcinoma with inferior vena caval invasion which is diagnosed by computed tomography and magnetic resonance imaging, and we treated surgery and postoperative chemotherapy.

Keyword

Adrenal cortical carcinoma; Inferior vena cava

MeSH Terms

Adrenocortical Carcinoma*
Diagnosis
Drug Therapy
Female
Humans
Incidence
Magnetic Resonance Imaging
Mitotane
Prognosis
Vena Cava, Inferior*
Mitotane